IN
Indivior Pharmaceuticals Inc (INDV)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$36.55
-2.30%
Mkt Cap $5.00B
Analyst Ratings
No recent rating data.
Price Target (14 analysts)
$48.00
Range $46.00 – $50.00
Implied Upside
+31.3%
Consensus $48.00 vs current $36.55